Editas Medicine Inc (EDIT)
5.62
+0.16
(+3.02%)
USD |
NASDAQ |
May 02, 16:00
5.73
+0.11
(+1.96%)
After-Hours: 17:35
Editas Medicine Cash from Operations (TTM): -132.18M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -132.18M |
September 30, 2023 | -152.21M |
June 30, 2023 | -164.76M |
March 31, 2023 | -163.89M |
December 31, 2022 | -177.35M |
September 30, 2022 | -169.66M |
June 30, 2022 | -162.44M |
March 31, 2022 | -163.55M |
December 31, 2021 | -163.80M |
September 30, 2021 | -169.32M |
June 30, 2021 | -183.34M |
March 31, 2021 | -175.24M |
December 31, 2020 | -179.84M |
September 30, 2020 | -98.72M |
June 30, 2020 | -70.80M |
March 31, 2020 | -65.75M |
December 31, 2019 | -40.67M |
Date | Value |
---|---|
September 30, 2019 | -80.37M |
June 30, 2019 | -61.32M |
March 31, 2019 | -52.25M |
December 31, 2018 | -45.71M |
September 30, 2018 | -72.10M |
June 30, 2018 | -92.24M |
March 31, 2018 | -101.67M |
December 31, 2017 | -9.417M |
September 30, 2017 | 1.975M |
June 30, 2017 | 12.91M |
March 31, 2017 | 29.17M |
December 31, 2016 | -50.25M |
September 30, 2016 | -44.58M |
June 30, 2016 | -39.48M |
March 31, 2016 | -9.129M |
December 31, 2015 | -5.443M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-183.34M
Minimum
Jun 2021
-40.67M
Maximum
Dec 2019
-135.54M
Average
-163.55M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
Vertex Pharmaceuticals Inc | 3.537B |
Moderna Inc | -3.118B |
Amicus Therapeutics Inc | -69.09M |
Geron Corp | -167.74M |
Regeneron Pharmaceuticals Inc | 4.594B |